New discoveries in circadian rhythms provide insight into cancer treatment

by Tiffany Trent,Virginia TechCarla Finkielstein shares notes with visiting student Xianlin Zou. Credit: Virginia TechIn a recent paper inScience Signaling, associate professor of cell and

Updated on: April 07,2024 13

New discoveries in circadian rhythms provide insight into cancer treatment

by Tiffany Trent,Virginia TechCarla Finkielstein shares notes with visiting student Xianlin Zou. Credit: Virginia TechIn a recent paper inScience Signaling, associate professor of cell and

Updated on:April 07,2024 13

Formation of new blood vessels in tumors regulated by p38 protein

by Institute for Research in Biomedicine (IRB Barcelona)Structure of a blood vessel. Credit: Raquel Batlle, IRB BarcelonaA study performed at the Institute for Research in Biomedicine(IRB Barcelo

Updated on: April 07,2024 19

Formation of new blood vessels in tumors regulated by p38 protein

by Institute for Research in Biomedicine (IRB Barcelona)Structure of a blood vessel. Credit: Raquel Batlle, IRB BarcelonaA study performed at the Institute for Research in Biomedicine(IRB Barcelo

Updated on:April 07,2024 19

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on: April 07,2024 19

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on:April 07,2024 19

Tumor mutations may predict response to immunotherapy

by Johns Hopkins University School of MedicineMismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, in certain genes when

Updated on: April 07,2024 16

Tumor mutations may predict response to immunotherapy

by Johns Hopkins University School of MedicineMismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, in certain genes when

Updated on:April 07,2024 16

Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

by Elana GotkineFactors contributing to disparities in cancer death include race/ethnicity, socioeconomic status, geographic location, and age, according to a study published online Nov. 14 inCA

Updated on: April 07,2024 19

Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

by Elana GotkineFactors contributing to disparities in cancer death include race/ethnicity, socioeconomic status, geographic location, and age, according to a study published online Nov. 14 inCA

Updated on:April 07,2024 19

Tumor suppressor gene variants identified as cancer 'double whammy' for leukemia patients

by St. Jude Children's Research HospitalJun J. Yang, Ph.D., identified 22 high-risk germline variations associated with high-risk acute lymphoblastic leukemia that increases risk of relapse o

Updated on: April 07,2024 18

Tumor suppressor gene variants identified as cancer 'double whammy' for leukemia patients

by St. Jude Children's Research HospitalJun J. Yang, Ph.D., identified 22 high-risk germline variations associated with high-risk acute lymphoblastic leukemia that increases risk of relapse o

Updated on:April 07,2024 18

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on: April 07,2024 15

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on:April 07,2024 15

Oncology researchers raise ethics concerns posed by patient-facing artificial intelligence

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainReady or not, patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies

Updated on: April 07,2024 11

Oncology researchers raise ethics concerns posed by patient-facing artificial intelligence

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainReady or not, patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies

Updated on:April 07,2024 11

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs

Updated on: April 07,2024 14

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs

Updated on:April 07,2024 14

Unraveling role of tumor suppressor in gene expression and ovarian tumorigenesis

by The Wistar InstituteCredit: CC0 Public DomainThe tumor suppressor protein ARID1A controls global transcription in ovarian epithelial cells, according to new research conducted at The Wistar In

Updated on: April 07,2024 11

Unraveling role of tumor suppressor in gene expression and ovarian tumorigenesis

by The Wistar InstituteCredit: CC0 Public DomainThe tumor suppressor protein ARID1A controls global transcription in ovarian epithelial cells, according to new research conducted at The Wistar In

Updated on:April 07,2024 11

Active surveillance feasible for small, low-grade bladder cancer

(HealthDay)—For patients who present with small, low-grade pTa/pT1a recurrent papillary bladder tumors, active surveillance appears to be a reasonable strategy, according to a study published in the F

Updated on: April 07,2024 10

Active surveillance feasible for small, low-grade bladder cancer

(HealthDay)—For patients who present with small, low-grade pTa/pT1a recurrent papillary bladder tumors, active surveillance appears to be a reasonable strategy, according to a study published in the F

Updated on:April 07,2024 10

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U

Updated on: April 07,2024 11

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U

Updated on:April 07,2024 11